
Auteur T. LEA
|
Documents disponibles écrits par cet auteur (4)

T. LEA ; M. HAMMOUD ; A. BOURNE ; L. MAHER ; F. JIN ; B. HAIRE ; N. BATH ; J. GRIERSON ; G. PRESTAGE | 2019
Dans Substance Use and Misuse (Vol.54, n°6, 2019) Article : PériodiqueBACKGROUND: Gay and bisexual men (GBM) report distinctive patterns and contexts of drug use, yet little has been published about their attitudes toward drug use. OBJECTIVES: We developed measures of attitudes and perceived social norms toward d[...]
T. LEA ; R. REYNOLDS ; J. DE WIT | 2011
Dans Drug and Alcohol Review (Vol.30, n°4, July 2011) Article : PériodiqueINTRODUCTION AND AIMS: Mephedrone (4-methylmethcathinone) is a synthetic stimulant that has recently emerged as a recreational drug. There is currently no Australian data on prevalence and patterns of mephedrone use. This paper aims to explore p[...]
T. LEA ; N. AMADA ; H. JUNGABERLE ; H. SCHECKE ; M. KLEIN | 2020
Dans International Journal of Drug Policy (Vol.75, January 2020) Article : PériodiqueBackground: In recent years there has been growing media attention on microdosing psychedelics (e.g., LSD, psilocybin). This refers to people routinely taking small doses of psychedelic substances to improve mental health and wellbeing, or to en[...]
A. R. WINSTOCK ; T. LEA ; A. RITTER | 2007
Dans Drug and Alcohol Review (Vol.26 n°4, 2007) Article : PériodiqueENGLISH : INTRODUCTION AND AIMS: The introduction of buprenorphine - naloxone in Australia in April 2006 has permitted the revision of takeaway policies in many states and has introduced the possibility of unsupervised treatment. This study ex[...]